Pharmacogenomics has transformed how clinicians reduce adverse drug reactions and optimise therapy. But real-world implementation still faces significant limitations. Can’t make the scheduled session?

We’re pleased to announce that registration is now open for The Festival of Genomics, Biodata & AI in Boston this June. As the life sciences sector rapidly evolves – notably due to the rise of AI – it ...

Scientific progress is often viewed as an unqualified good: faster sequencing, cheaper tests, and cutting-edge genomics tools seem to promise quicker diagnoses and personalised treatments. But for ...

How can genomics become embedded in our everyday lives, the same way that our phones, laptops and other modern tech have transformed the way we behave? In a recent episode of FoGCast, we had the ...

Are collaboration and consortia the key to reducing cost and improving confidence in liquid biopsies? If the ultimate goal of patient benefit is to be realised, all stakeholders must be convinced of ...

The metabolome consists of all the small molecules, or metabolites, which are components and products of biochemical reactions taking place within the body. Given its dynamic nature, metabolomics is a ...

This feature was written using content from out recenty published Proteomics Playbook, which you can download for FREE here. The sequence of a protein is critical as it largely dictates the protein’s ...

The microbiome is made of up trillions of microorganisms, each playing a crucial role – good or bad – in our health and wellbeing. Varying from one organ to another, and between every individual, the ...

Next generation sequencing (NGS) is a powerful tool for uncovering a patient’s inherited susceptibility to cancer, paving the way for more effective prevention strategies. However, hereditary cancer ...

Spatial biology isn’t just limited to transcriptomics. In fact, a vast array of spatial proteomics platforms also exist. But how can you find the right spatial proteomics approach? In this feature, we ...

Pinpointing pathogenic mutations from large, complex datasets can be difficult, time consuming and somewhat overwhelming. So, how can you best streamline your genomic analysis, to make it quicker, ...

As technology advances, we’re used to hearing about the latest in a seemingly never-ending list of ‘omics’. With each one hailed as more promising than the last, opportunities in the life sciences ...